Found 18 matching trials
Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso
PHASE2This study evaluated the persistence of immunity following primary typhoid ...
Location
Schiphra Protestant Hospital
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
PHASE3Phase III study, Randomized, observer blind, lot to lot consistency, non in...
Location
Jatinegara Primary Health Care
Vaccines Against Salmonella Typhi
PHASE2Using an established model of human typhoid infection, whereby healthy adul...
Location
Centre for Clinical Vaccinology and Tropical Medicine
Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh
PHASE1This is a double blinded, randomized-controlled, non-inferiority trial of a...
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
PHASE3This study will evaluate the efficacy of a Typhoid conjugate vaccine (Vi-TC...
Status
Active Not Recruiting
Location
Malawi Liverpool Wellcome Trust Clinical Research Programme, Queen Elizabeth Central Hospital College of Medicine
Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso
PHASE2Typhoid fever is an illness that may cause mild effects in children, such a...
Location
Groupe de Recherche Action en Santé (GRAS)
Co-administration Study of OCV, TCV and MR
PHASE3An open-label, randomized controlled, non-inferiority study of co-administr...
Location
Multiple Locations
Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine
PHASE3This is a Multicenter, observer-blinded, randomized, Active controlled, Pha...
Location
Nepalgunj medical college
Trivalent Salmonella Conjugate Vaccine (TSCV)
PHASE2This is an age-descending, randomized, placebo-controlled trial that will e...
Status
Active Not Recruiting
Location
Centre for Vaccine Development (CVD-Mali)
Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
PHASE2This is an observer-blinded, comparative, single dose, clinical phase II/II...
Location
De La Salle Medical and Health Sciences Institute